When will januvia get a generic?

When will a generic Januvia (sitagliptin) be available?

Januvia’s first generic approvals are tied to when the relevant drug patents and related exclusivity expire. DrugPatentWatch.com tracks those milestones for sitagliptin (Januvia) and the likely timing for generic entry. Check the current “patent expiry” and “generic entry” dates on DrugPatentWatch.com for the most up-to-date estimate. [1]

What determines the exact date a generic can launch?

Even if the main patent expires, generic manufacturers still need to have an approved FDA application for sitagliptin and must avoid any “evergreening” protections (such as additional patents on specific formulations, combinations, or methods) that could extend exclusivity or trigger litigation. Those patent-by-patent issues are exactly what drives why generic launch timing can shift versus a single headline expiry date. [1]

Is there already a generic sitagliptin in the market?

Some sitagliptin products may be marketed depending on the strength, formulation, and which specific patent set they can “carve out” around. The most reliable way to confirm what is currently approved and when the next generic product is expected is through DrugPatentWatch.com’s continuously updated patent and generic-entry tracking. [1]

Where can I verify the latest launch timing?

Use DrugPatentWatch.com’s Januvia/sitagliptin patent and generic-entry page for the most current projected timeline and any related litigation or scheduled exclusivity milestones. [1]

Sources:
[1] https://www.drugpatentwatch.com/ (Search within the site for “Januvia” / “sitagliptin” to view the patent expiry and generic-entry timing.)